Technical signals continue to point towards more gains for base metals, report technical analysts at Barclays Capital.
Citi has initiated coverage on QRxPharma, seeing significant upside potential as the company develops its products designed for the moderate-to-severe pain relief market.
China’s Q1 GDP growth beat market expectations, but does this mean policy response is imminent?
RBS looks at the US reporting season now underway while GSJB Were assesses earnings risk to local companies, plus more.
A glance through the latest expert views and predictions about commodities, where the latest news is positive for platinum, palladium and aluminium but less so for nickel and oil.
This week’s price action has reignited crude oil’s upward path, report technical analysts at Barclays Capital.
Morgan Stanley has initiated on 10 emerging companies with nine positive ratings, while both JP Morgan and Credit Suisse have also identified value elsewhere in the sector.
Macquarie notes a sharp drop off in sales of electronic goods while Merrill Lynch downgrades all food retailers.
Obama’s success at this week’s Nuclear Summit is probably not what investors in uranium were hoping for.
A revaluation of China’s currency could lend support to gold but both Barclays Capital and Standard Bank see the metal at risk of a short-term correction.
